• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B1和B2期黏液瘤样二尖瓣疾病犬的致心律失常特征研究

Study of the Arrhythmogenic Profile of Dogs with Myxomatous Mitral Valve Disease in Stages B1 and B2.

作者信息

Santos Beatriz Almeida, Corrêa Jaqueline Valença, Latini Carolina Dragone, Tsunemi Miriam Harumi, Alfonso Angélica, Machado Luiz Henrique de Araújo, Lourenço Maria Lucia Gomes

机构信息

School of Veterinary Medicine and Animal Science, São Paulo State University (Unesp), Botucatu 18618-681, Brazil.

Institute of Biosciences, São Paulo State University (Unesp), Botucatu 18618-689, Brazil.

出版信息

Vet Sci. 2024 Oct 1;11(10):467. doi: 10.3390/vetsci11100467.

DOI:10.3390/vetsci11100467
PMID:39453059
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11511566/
Abstract

Myxomatous mitral valve disease (MMVD) is the most prevalent cardiac disease in dogs. This study aimed to compare the arrhythmogenic profile and heart rate variability (HRV) of dogs with MMVD in stages B1 and B2. Electrocardiographic exams and the medical records of 60 dogs were analyzed, and HRV, P wave dispersion, QT interval dispersion, and QT interval instability parameters were determined. The results showed significantly increased values in stage B2 compared with stage B1 ( < 0.05) regarding P wave maximum and minimum duration (Pmax and Pmin) and short-term instability (STI). In contrast, no statistically significant differences were observed regarding HRV parameters, P wave dispersion, or QT interval dispersion. Our findings showed that cardiac remodeling in stage B2 could not significantly alter the sympathovagal balance and showed little interference with the predisposition of arrhythmias in dogs with MMVD.

摘要

黏液瘤样二尖瓣疾病(MMVD)是犬类中最常见的心脏疾病。本研究旨在比较处于B1和B2阶段的MMVD犬的致心律失常特征和心率变异性(HRV)。分析了60只犬的心电图检查结果和病历,并测定了HRV、P波离散度、QT间期离散度和QT间期不稳定性参数。结果显示,与B1阶段相比,B2阶段的P波最大和最小持续时间(Pmax和Pmin)以及短期不稳定性(STI)值显著升高(<0.05)。相比之下,在HRV参数、P波离散度或QT间期离散度方面未观察到统计学上的显著差异。我们的研究结果表明,B2阶段的心脏重塑不会显著改变交感迷走神经平衡,并且对MMVD犬的心律失常易感性干扰较小。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131b/11511566/8fdcded73203/vetsci-11-00467-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131b/11511566/a93ee52ca582/vetsci-11-00467-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131b/11511566/8fdcded73203/vetsci-11-00467-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131b/11511566/a93ee52ca582/vetsci-11-00467-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131b/11511566/8fdcded73203/vetsci-11-00467-g002.jpg

相似文献

1
Study of the Arrhythmogenic Profile of Dogs with Myxomatous Mitral Valve Disease in Stages B1 and B2.B1和B2期黏液瘤样二尖瓣疾病犬的致心律失常特征研究
Vet Sci. 2024 Oct 1;11(10):467. doi: 10.3390/vetsci11100467.
2
QT instability, an indicator of augmented arrhythmogenesis, increases with the progression of myxomatous mitral valve disease in dogs.QT间期不稳定是心律失常增加的一个指标,它会随着犬黏液瘤性二尖瓣疾病的进展而增加。
J Vet Cardiol. 2018 Aug;20(4):254-266. doi: 10.1016/j.jvc.2018.06.002. Epub 2018 Jul 18.
3
T-wave peak-end interval and ratio of T-wave peak-end and QT intervals: novel arrhythmogenic and survival markers for dogs with myxomatous mitral valve disease.T 波峰末间期和 T 波峰末间期与 QT 间期的比值:黏液样二尖瓣病变犬的新型致心律失常和生存标志物。
J Vet Cardiol. 2021 Jun;35:25-41. doi: 10.1016/j.jvc.2021.02.004. Epub 2021 Feb 27.
4
Sildenafil improves heart rate variability in dogs with asymptomatic myxomatous mitral valve degeneration.西地那非可改善无症状黏液瘤样二尖瓣退变犬的心率变异性。
J Vet Med Sci. 2017 Sep 12;79(9):1480-1488. doi: 10.1292/jvms.17-0016. Epub 2017 Jul 17.
5
Diagnostic value of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP) and their correlation with lipoproteins in dogs with myxomatous mitral valve disease.在患有黏液样二尖瓣疾病的犬中,心钠肽 (ANP)、B 型利钠肽 (BNP) 的诊断价值及其与脂蛋白的相关性。
BMC Vet Res. 2022 Dec 23;18(1):448. doi: 10.1186/s12917-022-03548-2.
6
Assessment of heart rate turbulence in dogs with myxomatous mitral valve disease.评估黏液样二尖瓣病变犬的心率震荡。
Open Vet J. 2021 Oct-Dec;11(4):635-644. doi: 10.5455/OVJ.2021.v11.i4.13. Epub 2021 Nov 13.
7
Proteomics reveals plasma protein SERPINH1 as a potential diagnostic biomarkers for myxomatous mitral valve disease stage B2.蛋白质组学揭示血浆蛋白 SERPINH1 作为黏液样二尖瓣病变 B2 期的潜在诊断生物标志物。
J Proteomics. 2023 Jun 30;282:104924. doi: 10.1016/j.jprot.2023.104924. Epub 2023 May 3.
8
Iron parameters analysis in dogs with myxomatous mitral valve disease.犬黏液瘤性二尖瓣疾病的铁参数分析。
BMC Vet Res. 2024 May 18;20(1):210. doi: 10.1186/s12917-024-04071-2.
9
Serum Proteomic Profiles Reflect the Stages of Myxomatous Mitral Valve Disease in Dogs.血清蛋白质组谱反映犬黏液样变性二尖瓣疾病的阶段。
Int J Mol Sci. 2023 Apr 12;24(8):7142. doi: 10.3390/ijms24087142.
10
Myxomatous Mitral Valve Disease in Large Breed Dogs: Survival Characteristics and Prognostic Variables.大型犬黏液瘤性二尖瓣疾病:生存特征与预后变量
Vet Sci. 2024 Mar 21;11(3):136. doi: 10.3390/vetsci11030136.

引用本文的文献

1
Study of the Arrhythmogenic Profile in Dogs with Acute and Chronic Monocytic Ehrlichiosis.急性和慢性单核细胞埃立克体病犬的致心律失常特征研究
Life (Basel). 2025 Mar 18;15(3):490. doi: 10.3390/life15030490.

本文引用的文献

1
Short-term heart rate variability in healthy dogs and dogs in various stages of degenerative mitral valve disease evaluated before pharmacotherapy.健康犬和处于退行性二尖瓣病变不同阶段犬在药物治疗前的短期心率变异性。
Vet J. 2021 Aug;274:105704. doi: 10.1016/j.tvjl.2021.105704. Epub 2021 Jun 5.
2
Heart Rate Variability and Electrocardiographic Parameters Predictive of Arrhythmias in Dogs with Stage IV Chronic Kidney Disease Undergoing Intermittent Haemodialysis.心率变异性和心电图参数对接受间歇性血液透析的IV期慢性肾病犬心律失常的预测作用
Animals (Basel). 2020 Oct 8;10(10):1829. doi: 10.3390/ani10101829.
3
Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.
人类与犬黏液瘤样二尖瓣退变的比较病理学:5-羟色胺与转化生长因子-β机制
Cardiovasc Pathol. 2020 May-Jun;46:107196. doi: 10.1016/j.carpath.2019.107196. Epub 2020 Jan 7.
4
ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs.ACVIM 共识指南:犬黏液瘤性二尖瓣疾病的诊断与治疗。
J Vet Intern Med. 2019 May;33(3):1127-1140. doi: 10.1111/jvim.15488. Epub 2019 Apr 11.
5
QT instability, an indicator of augmented arrhythmogenesis, increases with the progression of myxomatous mitral valve disease in dogs.QT间期不稳定是心律失常增加的一个指标,它会随着犬黏液瘤性二尖瓣疾病的进展而增加。
J Vet Cardiol. 2018 Aug;20(4):254-266. doi: 10.1016/j.jvc.2018.06.002. Epub 2018 Jul 18.
6
P-wave dispersion: an update.P波离散度:最新进展
Indian Pacing Electrophysiol J. 2016 Jul-Aug;16(4):126-133. doi: 10.1016/j.ipej.2016.10.002. Epub 2016 Oct 20.
7
Heart Rate Variability as a Method for Assessment of the Autonomic Nervous System and the Adaptations to Different Physiological and Pathological Conditions.心率变异性作为评估自主神经系统以及对不同生理和病理状况适应性的一种方法。
Folia Med (Plovdiv). 2015 Jul-Dec;57(3-4):173-80. doi: 10.1515/folmed-2015-0036.
8
Heart rate variability.心率变异性
Handb Clin Neurol. 2013;117:379-93. doi: 10.1016/B978-0-444-53491-0.00031-6.
9
Heart rate variability today.心率变异性今日谈。
Prog Cardiovasc Dis. 2012 Nov-Dec;55(3):321-31. doi: 10.1016/j.pcad.2012.09.001.
10
Heart rate variability parameters of myxomatous mitral valve disease in dogs with and without heart failure obtained using 24-hour Holter electrocardiography.使用 24 小时动态心电图获取有和无心力衰竭的黏液瘤性二尖瓣疾病犬的心率变异性参数。
Vet Rec. 2012 Jun 16;170(24):622. doi: 10.1136/vr.100202. Epub 2012 May 29.